{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:58:01Z","timestamp":1780567081758,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00408-019-00203-w","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T08:51:33Z","timestamp":1550047893000},"page":"147-153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pirfenidone Therapy for Familial Pulmonary Fibrosis: A Real-Life Study"],"prefix":"10.1007","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5354-152X","authenticated-orcid":false,"given":"David","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Metella","family":"Refini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucia","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Fui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Fossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pieroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Mazzei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rottoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"issue":"6","key":"203_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D, ATS\/ERS Committee on Idiopathic Interstitial Pneumonias (2013) An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188(6):733\u2013748","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"203_CR2","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1378\/chest.127.6.2034","volume":"127","author":"HL Lee","year":"2005","unstructured":"Lee HL, Ryu JH, Wittmer MH, Hartman TE, Lymp JF, Tazelaar HD, Limper AH (2005) Familial idiopathic pulmonary fibrosis: clinical features and outcome. Chest 127(6):2034\u20132041","journal-title":"Chest"},{"issue":"1","key":"203_CR3","first-page":"28","volume":"31","author":"C Ravaglia","year":"2014","unstructured":"Ravaglia C, Tomassetti S, Gurioli C, Piciucchi S, Dubini A, Gurioli C, Casoni GL, Romagnoli M, Carloni A, Tantalocco P, Buccioli M, Chilosi M, Poletti V (2014) Features and outcome of familial idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 31(1):28\u201336","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"203_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12916-015-0434-0","volume":"13","author":"SK Mathai","year":"2015","unstructured":"Mathai SK, Yang IV, Schwarz MI, Schwartz DA (2015) Incorporating genetics into the identification and treatment of idiopathic pulmonary fibrosis. BMC Med 13:191","journal-title":"BMC Med"},{"issue":"2","key":"203_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1513\/pats.201008-056MS","volume":"8","author":"CK Garcia","year":"2011","unstructured":"Garcia CK (2011) Idiopathic pulmonary fibrosis: update on genetic discoveries. Proc Am Thorac Soc 8(2):158\u2013162","journal-title":"Proc Am Thorac Soc"},{"issue":"5","key":"203_CR6","doi-asserted-by":"publisher","first-page":"e10680","DOI":"10.1371\/journal.pone.0010680","volume":"5","author":"A Diaz de Leon","year":"2010","unstructured":"Diaz de Leon A, Cronkhite JT, Katzenstein AL, Godwin JD, Raghu G, Glazer CS, Rosenblatt RL, Girod CE, Garrity ER, Xing C, Garcia CK (2010) Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS ONE 5(5):e10680","journal-title":"PLoS ONE"},{"issue":"8","key":"203_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1056\/NEJM200102223440805","volume":"344","author":"LM Nogee","year":"2001","unstructured":"Nogee LM, Dunbar AE III, Wert SE, Askin F, Hamvas A, Whitsett JA (2001) A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 344(8):573\u2013579","journal-title":"N Engl J Med"},{"key":"203_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1465-9921-15-43","volume":"15","author":"I Campo","year":"2014","unstructured":"Campo I, Zorzetto M, Mariani F, Kadija Z, Morbini P, Dore R, Kaltenborn E, Frixel S, Zarbock R, Liebisch G, Hegermann J, Wrede C, Griese M, Luisetti M (2014) A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant. Respir Res 15:43","journal-title":"Respir Res"},{"key":"203_CR9","doi-asserted-by":"publisher","first-page":"20832092","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr","year":"2014","unstructured":"King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW, ASCEND Study Group (2014) A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370:2083\u20132092","journal-title":"N Engl J Med"},{"key":"203_CR10","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","volume":"377","author":"PW Noble","year":"2011","unstructured":"Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE Jr, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM, CAPACITY Study Group (2011) Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomized trials. Lancet 377:1760\u20131769","journal-title":"Lancet"},{"issue":"22","key":"203_CR11","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR, INPULSIS Trial Investigators (2014) Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370(22):2071\u20132082","journal-title":"N Engl J Med"},{"issue":"5","key":"203_CR12","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, Flaherty KR, Wells A, Martinez FJ, Azuma A, Bice TJ, Bouros D, Brown KK, Collard HR, Duggal A, Galvin L, Inoue Y, Jenkins RG, Johkoh T, Kazerooni EA, Kitaichi M, Knight SL, Mansour G, Nicholson AG, Pipavath SNJ, Buend\u00eda-Rold\u00e1n I, Selman M, Travis WD, Walsh S, Wilson KC, American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society (2018) Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 198(5):e44\u2013e68","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"203_CR13","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","volume":"185","author":"KC Meyer","year":"2012","unstructured":"Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, Drent M, Haslam PL, Kim DS, Nagai S, Rottoli P, Saltini C, Selman M, Strange C, Wood B, American Thoracic Society Committee on BAL in Interstitial Lung Disease (2012) An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 185(9):1004\u20131014. \n                    https:\/\/doi.org\/10.1164\/rccm.201202-0320ST","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"203_CR14","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.rmed.2015.04.010","volume":"109","author":"S Harari","year":"2015","unstructured":"Harari S, Caminati A, Albera C, Vancheri C, Poletti V, Pesci A, Luppi F, Saltini C, Agostini C, Bargagli E, Sebastiani A, Sanduzzi A, Giunta V, Della Porta R, Bandelli GP, Puglisi S, Tomassetti S, Biffi A, Cerri S, Mari A, Cinetto F, Tirelli F, Farinelli G, Bocchino M, Specchia C, Confalonieri M (2015) Efficacy of pirfenidone for idiopathic pulmonary fibrosis: an Italian real life study. Respir Med 109(7):904\u2013913","journal-title":"Respir Med"},{"key":"203_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.rmed.2017.03.020","volume":"126","author":"D Bennett","year":"2017","unstructured":"Bennett D, Mazzei MA, Squitieri NC, Bargagli E, Refini RM, Fossi A, Volterrani L, Rottoli P (2017) Familial pulmonary fibrosis: clinical and radiological characteristics and progression analysis in different high resolution-CT patterns. Respir Med 126:75\u201383","journal-title":"Respir Med"},{"issue":"1","key":"203_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S2213-2600(16)30222-3","volume":"5","author":"CS King","year":"2017","unstructured":"King CS, Nathan SD (2017) Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities. Lancet Respir Med 5(1):72\u201384","journal-title":"Lancet Respir Med"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-019-00203-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-019-00203-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-019-00203-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T19:10:22Z","timestamp":1581534622000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-019-00203-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["203"],"URL":"https:\/\/doi.org\/10.1007\/s00408-019-00203-w","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]},"assertion":[{"value":"23 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Bennett reports personal fees from Boehringer Ingelheim, personal fees from Roche, personal fees from Biotest, outside the submitted work. Prof. Rottoli reports personal fees and other from Roche, personal fees from Boehringer ingelheim, grants and personal fees from Novartis, personal fees from TEVA, other from Menarini, outside the submitted work. Dr. Rosa Metella Refini, Dr. Maria Lucia Valentini, Dr. Annalisa Fui, Dr. Antonella Fossi, Dr. Maria Pieroni and Prof. Maria Antonietta Mazzei and have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}